# Grand Pharmaceutical

markets SIR-Spheres Yttrium-90 microspheres (Yigantai) for selective internal radiation therapy of liver cancer, and its US DOORwaY90 clinical trial met its primary endpoint for unresectable hepatocellular carcinoma; the company is building China's largest radiopharmaceutical production base in Wuhan.

Source: https://en.bioecon.ru/companies/grand-pharmaceutical/
Updated: 2026-07-03

- Country: China

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | HK$12.28 billion (2025) | https://flcube.com/?p=61514, https://newsfile.moomoo.com/public/NN-PersistNoticeAttachment/7781/20260326/12070908-0.PDF |
| Headcount | 12,614 (as of 2025) | https://newsfile.moomoo.com/public/NN-PersistNoticeAttachment/7781/20260326/12070908-0.PDF, https://www.marketscreener.com/news/grand-pharmaceutical-group-limited-reports-earnings-results-for-the-full-year-ended-december-31-202-ce7e51dbd98ff621, https://www.morningstar.com.au/investments/security/HKSE/00512, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| Production site | Boston, Frankfurt, Singapore, and Chengdu | https://www.grandpharm.com/en/news/grand-pharmas-world-first-closed-loop-platform-nuclear-medicine-rd-and-production-base-is-about-to-be-put-into-operation/, https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| Capacity | 14 high-standard GMP production lines at Chengdu base | https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| Regulatory approval | FDA approved for unresectable HCC and colorectal cancer liver metastases | https://allsci.com/news/clinical-trials/grand-pharmas-sir-spheres-y-90-aces-endpoints-in-hcc-phase-iii/, https://www.grandpharm.com/en/news/a-new-indication-of-grand-phamras-globally-innovative-radioactive-product-sir-spheres-y-90-resin-microsphere-injection-is-officially-approved-by-the-fda-ahead-of-schedule/, https://www.sirtex.com/us/news/press-releases/news-item?id=5517, https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |
| Certification | Class A Radiation Safety Licence (Chengdu facility) | https://www.grandpharm.com/en/news/grand-pharmas-world-first-closed-loop-platform-nuclear-medicine-rd-and-production-base-is-about-to-be-put-into-operation/, https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0518/2025051800011.pdf, https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0413/2026041301312.pdf |

Independent sources: allsci.com, flcube.com, marketscreener.com, morningstar.com.au, newsfile.moomoo.com, sirtex.com, www1.hkexnews.hk

## Technologies

- [Radiopharmaceuticals & theranostics](https://en.bioecon.ru/technology/radiopharmaceuticals-theranostics/)